WS #15763
UnitedHealth Group delivered a standout earnings report, beating third-quarter estimates and raising full-year EPS guidance to at least $20.50. The company successfully managed its medical loss ratio, which came in 1.5 percentage points lower than expected, demonstrating strong cost control in a challenging healthcare environment. This performance reinforces the defensive appeal of the healthcare sector as investors seek stability amidst the broader tech sector's volatility.
Healthcare Earnings
UnitedHealth Group delivered a standout earnings report, beating third-quarter estimates and raising full-year EPS guidance to at least $20.50. The company successfully managed its medical loss ratio, which came in 1.5 percentage points lower than expected, demonstrating strong cost control in a challenging healthcare environment. This performance reinforces the defensive appeal of the healthcare sector as investors seek stability amidst the broader tech sector's volatility.